Chemotherapy for ovarian cancer--a consensus statement on standard practice.
Authors
Adams, MCalvert, A H
Carmichael, J
Clark, P I
Coleman, R E
Earl, H M
Gallagher, C J
Ganesan, T S
Gore, M E
Graham, J D
Harper, P G
Jayson, Gordon C
Kaye, Stan B
Ledermann, J A
Osborne, R J
Perren, T J
Poole, C J
Radford, John A
Rustin, G J
Slevin, M L
Smyth, J F
Thomas, H
Wilkinson, Peter M
Issue Date
1998-12
Metadata
Show full item recordCitation
Chemotherapy for ovarian cancer--a consensus statement on standard practice. 1998, 78 (11):1404-6 Br. J. CancerJournal
British Journal of CancerPubMed ID
9836470Type
ArticleLanguage
enISSN
0007-0920Collections
Related articles
- ICON3 and chemotherapy for ovarian cancer.
- Authors: Ozols RF, Markman M, Thigpen JT
- Issue date: 2002 Dec 21-28
- Chemotherapy for ovarian cancer--trials, controversies and funding.
- Authors: Hawkins RE
- Issue date: 1998 Dec
- Carboplatin versus cisplatin in ovarian cancer.
- Authors: Alberts DS
- Issue date: 1995 Oct
- Is paclitaxel/carboplatin really a useful regimen for ovarian cancer compared with platinum/doxorubicin/cyclophosphamide?
- Authors: Sugiyama T
- Issue date: 2006 Jun
- ICON2 trial. UK consensus statement on standard practice for chemotherapy in ovarian cancer.
- Authors: Gore ME
- Issue date: 1999 Feb 13